A string of ASX-listed drug developers is due to release company-making – or breaking – pivotal clinical study results in ...

Bio-Rad Laboratories, Inc., a global leader in life science research and clinical diagnostics products, today announced the ...

CAMBRIDGE, Mass., April 9, 2026 /PRNewswire/ -- Deck Bio today launches with a multi-target approach designed to expand the reach of T cell engagers in solid tumors by addressing tumor heterogeneity ...

These findings are important because they suggest that more selective JAK inhibition, particularly targeting JAK1 or JAK2, can effectively reduce organ pathology and pathogenic IFN-γ-producing immune ...

Using single-nucleus RNA sequencing, the authors map transcriptional changes in the rat ventral tegmental area following chronic inflammatory pain and acute morphine exposure. Notably, their ...

Bio X Cell today announces new peer-reviewed findings demonstrating that its functional antibodies maintain consistent performance across both murine in vivo models and human-relevant organoid systems ...

Imagine receiving a test result that tells you your body is biologically five years older than your chronological age. You ...

New research shows how certain orphan noncoding RNA — oncRNA — can be predictable enough to be a ‘bar code’ identifying specific cancers. Liquid biopsy could be next.

We independently review everything we recommend. When you buy through our links, we may earn a commission. Learn more› By Rachel Wharton Rachel Wharton is a writer covering kitchen appliances. For ...

IIIF provides researchers rich metadata and media viewing options for comparison of works across cultural heritage collections. Visit the IIIF page to learn more. In 1949, Wallace H. Coulter ...

Nato’s new 1.5 per cent resilience target marks a turning point in how the Alliance approaches threats beyond the battlefield, from biological attacks to cyber warfare. But will it actually make us ...